Piramal Pharma Acquires 40.67 Percent Additional Stake in Yapan Bio for INR 76 Crore
Piramal Pharma acquires an additional 40.67 percent stake in Yapan Bio for INR 76 crore, raising its ownership to 74 percent and expanding its biologics Contract Development and Manufacturing Organisation (CDMO) capabilities.
Good Manufacturing Practice (GMP) | 18/08/2026 | By News Bureau
Gland Pharma and Neuland Partner for Sterile API Manufacturing
Gland Pharma and Neuland Laboratories have partnered to expand sterile Active Pharmaceutical Ingredient (API) manufacturing through a new state-of-the-art current Good Manufacturing Practice (GMP) sterile manufacturing suite.
Good Manufacturing Practice (GMP) | 06/08/2026 | By News Bureau
Cipla's InvaGen Receives US FDA EIR for New York Manufacturing Facility
Cipla's subsidiary InvaGen has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA), marking the successful closure of the inspection at its New York facility.
Good Manufacturing Practice (GMP) | 04/08/2026 | By News Bureau
NMPA Reviews QMS for Vaccine and Drug GMP Compliance
China's NMPA has completed a QMS management review to strengthen vaccine and drug Good Manufacturing Practice (GMP) compliance, supporting WHO WLA standards and PIC/S regulatory requirements.
Good Manufacturing Practice (GMP) | 13/07/2026 | By News Bureau
PharmAla Completes GMP Manufacturing for ALA-002
PharmAla has completed GMP manufacturing of ALA-002 drug substance components and is preparing to begin GMP drug product manufacturing for upcoming global clinical trials.
Good Manufacturing Practice (GMP) | 07/07/2026 | By News Bureau
EDQM Audit Finds Anuh Pharma Facility Compliant
Anuh Pharma has cleared a Good Manufacturing Practice (GMP) milestone following a successful audit by the European Directorate for the Quality of Medicines & HealthCare at its bulk drug manufacturing facility in Tarapur, Maharashtra, the company said in a stock exchange filing.
Good Manufacturing Practice (GMP) | 11/03/2026 | By News Bureau | 158
WuXi Biologics' Wuxi Facilities Receive MHRA GMP Approval for Ophthalmic Biologic Manufacturing
The UK regulator has certified WuXi Biologics’ DP5 and DPPC sites in Wuxi for commercial production, reinforcing the company’s global GMP-compliant manufacturing capabilities.
Good Manufacturing Practice (GMP) | 13/01/2026 | By News Bureau | 258
USFDA Concludes Inspection at Dr. Reddy's Srikakulam Facility with VAI Classification
Dr. Reddy’s Laboratories has announced that the United States Food and Drug Administration (USFDA) has completed a Good Manufacturing Practice (GMP) and Pre-Approval Inspection (PAI) at its formulations manufacturing facility (FTO 11) in Srikakulam, Andhra Pradesh.
Good Manufacturing Practice (GMP) | 21/10/2025 | By Dineshwori | 514
Biocon's Cranbury Facility in US Passes FDA Inspection, Supports Expansion Plans
Biocon’s inspection concluded with a single observation, which the company will address within the stipulated timeframe, and it is not expected to impact ongoing business operations
Good Manufacturing Practice (GMP) | 15/10/2025 | By Dineshwori | 292
Promocell Enters GMP Field with Launch of Custom Cell Culture Media Services
PromoCell GmbH has announced its entry into the Good Manufacturing Practice (GMP) field with the launch of custom cell culture media services designed specifically for cell-based therapy and regenerative medicine.
Good Manufacturing Practice (GMP) | 01/10/2025 | By Dineshwori | 336
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy